Viewing Study NCT01153932


Ignite Creation Date: 2025-12-24 @ 9:28 PM
Ignite Modification Date: 2026-01-04 @ 8:34 AM
Study NCT ID: NCT01153932
Status: COMPLETED
Last Update Posted: 2014-08-25
First Post: 2010-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Muscular Dystrophies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 968 View
None muscular dystrophy View
None duchenne View
None DMD View